EntreMed Sees Positive Study Results
14th Nov 2006, 16:19 GMT
Biopharmaceutical company EntreMed said preclinical results from its developing rheumatoid arthritis treatment candidate showed the drug reduced joint inflammation in animals.
EntreMed Sees Positive Study Results related news:
- Positive Results for Anti-Cholesterol Drug — NYT > Business
- ZymoGenetics, Serono present positive results for atacicept — Pharmaceutical Business Review Latest News
- Arqule Early Cancer Study Shows Progress — Bio-Technology News from StratCenter.com
- Amgen Releases Long-Term Enbrel Data — Bio-Technology News from StratCenter.com
- Pharmos Completes Phase 1 Study of Topical Diclofenac NanoEmulsion Cream — Orthopedics News from StratCenter.com
- HGS reports positive Lupus drug test results — StratWire - Business of Healthcare NewsFeed
- Human Genome reports positive results on lupus drug — Pharmaceutical Business Review Latest News
- Study: Bioenergy sugar product useful for chronic fatigue syndrome — bizjournals.com Health Care:Pharmaceuticals headlines
- Human Genome Says Lupus Drug Promising — Operations-Related News from StratCenter.com
- Clinical Reevaluation of the QuantiFERON TB-2G Test as a Diagnostic Method for Differentiating Active Tuberculosis from Nontuberculous Mycobacteriosis — Clin Infect Dis Latest Articles
Latest news from Operations-Related News from StratCenter.com:
- Senior Housing Properties Trust Announces Proposed Public Offering of 5 mln Common Shares
- King Not Loving Its Shareholders
- Sepracor says asthma drug data is favorable
- Sepracor Presents Data on Asthma Drug
- Dr Reddy's Registers to List Shares
- PolyMedica Corp CEO to Ring the NASDAQ Stock Market Opening Bell
- Biovail to Present at the CSFB 2006 Healthcare Conference
- Genelabs reports lower Q3 loss
- Solexa posts narrowed Q3 loss
- Abbott's Humira Positive in 2 Studies